Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2007Avian Diseases

Determination of Optimal Conditions for Thawing and Diluting Cell-Bound CVI 988 Marek's Disease Vaccine and Stability of the Diluted Vaccine

View Full Paper
Ask AI
Bookmark
Share

Authors

HGH.J. GeerligsZoetis (Belgium)AHA. Hoogendam

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Geerligs et al. (2007) studied this question.

synapsesocial.com/papers/6aacb50ac7e070df51ecbfb9https://doi.org/10.1637/7818-121506-resnoter2.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influence of Some Physical Factors on Survival of Marek's Disease Vaccine Virus1975 · 19 citations
  2. 2Control of Marek's Disease in the Netherlands. I. Isolation of an Avirulent Marek's Disease Virus (Strain CVI 988) and Its Use in Laboratory Vaccination Trials1972 · 337 citations
  3. 3Titration of Marek's Disease Cell-Associated Vaccine Virus (CVI 988) of Reconstituted Vaccine and Vaccine Ampoules from Dutch Hatcheries2003 · 25 citations
  4. 4Loss of Cell-Associated Marek's Disease Vaccine Titer during Thawing, Reconstitution, and Use1979 · 21 citations
  5. 5Isolation from Turkeys of a Cell-Associated Herpesvirus Antigenically Related to Marek's Disease Virus1970 · 481 citations